{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:05:00Z","timestamp":1772751900244,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T00:00:00Z","timestamp":1334275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T00:00:00Z","timestamp":1334275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00213-012-2706-0","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T23:15:25Z","timestamp":1334186125000},"page":"191-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to l-DOPA"],"prefix":"10.1007","volume":"223","author":[{"given":"Ilya D.","family":"Ionov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas N.","family":"Severtsev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,13]]},"reference":[{"key":"2706_CR1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1476-5381.1979.tb07831.x","volume":"65","author":"YZ Abou","year":"1979","unstructured":"Abou YZ, Farjo IB (1979) Reversal of DOPA-induced arousal in reserpine-treated rabbits and mice by histidine. Br J Pharmacol 65:303\u2013309","journal-title":"Br J Pharmacol"},{"key":"2706_CR2","first-page":"45","volume":"532","author":"LF Agnati","year":"1984","unstructured":"Agnati LF, Fuxe K, Benfenati F, Toffano G, Cimino M, Battistini N, Calza L, Merlo Pich E (1984) III. Studies on aging processes. Acta Physiol Scand Suppl 532:45\u201361","journal-title":"Acta Physiol Scand Suppl"},{"key":"2706_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2010.11.054","volume":"489","author":"E Allen","year":"2011","unstructured":"Allen E, Carlson KM, Zigmond MJ, Cavanaugh JE (2011) l-DOPA reverses motor deficits associated with normal aging in mice. Neurosci Lett 489:1\u20134","journal-title":"Neurosci Lett"},{"key":"2706_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000123078","volume":"31","author":"KT Demarest","year":"1980","unstructured":"Demarest KT, Riegle GD, Moore KE (1980) Characteristics of dopaminergic neurons in the aged male rat. Neuroendocrinology 31:222\u2013227","journal-title":"Neuroendocrinology"},{"key":"2706_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/PL00005274","volume":"358","author":"HC Dringenberg","year":"1998","unstructured":"Dringenberg HC, de Souza-Silva MA, Schwarting RK, Huston JP (1998) Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade. Naunyn Schmiedebergs Arch Pharmacol 358:423\u2013429","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2706_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/jnnp.56.1.65","volume":"56","author":"R Durso","year":"1993","unstructured":"Durso R, Isaac K, Perry L, Saint-Hilaire M, Feldman RG (1993) Age influences magnitude but not duration of response to levodopa. J Neurol Neurosurg Psychiatry 56:65\u201368","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2706_CR7","first-page":"104","volume-title":"Psychotropic drugs","author":"C Fazio","year":"1957","unstructured":"Fazio C, Sacchi U (1957) Experimental catalepsy produced by substances introduced into subaracnoid spaces and ventricles. In: Garattini S, Ghetti V (eds) Psychotropic drugs. Elsevier, Amsterdam, pp 104\u2013109"},{"key":"2706_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.05.008","volume":"55","author":"C Ferrada","year":"2008","unstructured":"Ferrada C, Ferr\u00e9 S, Casad\u00f3 V, Cort\u00e9s A, Justinova Z, Barnes C, Canela EI, Goldberg SR, Leurs R, Lluis C, Franco R (2008) Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 55:190\u2013197","journal-title":"Neuropharmacology"},{"key":"2706_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ana.410260403","volume":"26","author":"DC German","year":"1989","unstructured":"German DC, Manaye K, Smith WK, Woodward DJ, Saper CB (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 26:507\u2013514","journal-title":"Ann Neurol"},{"key":"2706_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/mds.870120303","volume":"12","author":"G Gomez Arevalo","year":"1997","unstructured":"Gomez Arevalo G, Jorge R, Garcia S, Scipioni O, Gershanik O (1997) Clinical and pharmacological differences in early- versus late-onset Parkinson's disease. Mov Disord 12:277\u2013284","journal-title":"Mov Disord"},{"key":"2706_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s002210050866","volume":"128","author":"RU Hasen\u00f6hrl","year":"1999","unstructured":"Hasen\u00f6hrl RU, Weth K, Huston JP (1999) Intraventricular infusion of the histamine H1 receptor antagonist chlorpheniramine improves maze performance and has anxiolytic-like effects in aged hybrid Fischer 344xBrown Norway rats. Exp Brain Res 128:435\u2013440","journal-title":"Exp Brain Res"},{"key":"2706_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/ageing\/afp223","volume":"39","author":"JV Hindle","year":"2010","unstructured":"Hindle JV (2010) Ageing, neurodegeneration and Parkinson's disease. Age Ageing 39:156\u2013161","journal-title":"Age Ageing"},{"key":"2706_CR13","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.neurobiolaging.2007.04.012","volume":"29","author":"Y Huang","year":"2008","unstructured":"Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP (2008) Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging 29:1744\u20131753","journal-title":"Neurobiol Aging"},{"key":"2706_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0304-3940(84)90055-7","volume":"48","author":"Y Itoh","year":"1984","unstructured":"Itoh Y, Nishibori M, Oishi R, Saeki K (1984) Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice. Neurosci Lett 48:305\u2013309","journal-title":"Neurosci Lett"},{"key":"2706_CR15","first-page":"503","volume":"25","author":"E Jagiello-W\u00f3jtowicz","year":"1973","unstructured":"Jagiello-W\u00f3jtowicz E (1973) The central action of histamine. I. The effect of intraventricular histamine on the rat behavior. Pol J Pharmacol Pharm 25:503\u2013510","journal-title":"Pol J Pharmacol Pharm"},{"key":"2706_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/mds.23069","volume":"25","author":"TH Johnston","year":"2010","unstructured":"Johnston TH, van der Meij A, Brotchie JM, Fox SH (2010) Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease. Mov Disord 25:1379\u20131390","journal-title":"Mov Disord"},{"key":"2706_CR17","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1254\/jjp.33.1081","volume":"33","author":"C Kamei","year":"1983","unstructured":"Kamei C, Dabasaki T, Tasaka K (1983) Cataleptic effect of histamine induced by intraventricular injection in mice. Jpn J Pharmacol 33:1081\u20131084","journal-title":"Jpn J Pharmacol"},{"key":"2706_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0091-3057(88)90149-9","volume":"29","author":"WR Klemm","year":"1988","unstructured":"Klemm WR, Block H (1988) D1 and D2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways. Pharmacol Biochem Behav 29:223\u2013229","journal-title":"Pharmacol Biochem Behav"},{"key":"2706_CR19","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/S0024-3205(97)01007-2","volume":"61","author":"T Kobayashi","year":"1997","unstructured":"Kobayashi T, Araki T, Itoyama Y, Takeshita M, Ohta T, Oshima Y (1997) Effects of l-dopa and bromocriptine on haloperidol-induced motor deficits in mice. Life Sci 61:2529\u20132538","journal-title":"Life Sci"},{"key":"2706_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.pbb.2008.03.010","volume":"90","author":"CQ Liu","year":"2008","unstructured":"Liu CQ, Hu DN, Liu FX, Chen Z, Luo JH (2008) Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist. Pharmacol Biochem Behav 90:325\u2013330","journal-title":"Pharmacol Biochem Behav"},{"key":"2706_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s002210050401","volume":"120","author":"S Maisonnette","year":"1998","unstructured":"Maisonnette S, Huston JP, Brandao M, Schwarting RK (1998) Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra. Exp Brain Res 120:273\u2013282","journal-title":"Exp Brain Res"},{"key":"2706_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00001756-200001170-00032","volume":"11","author":"A Molina-Hernandez","year":"2000","unstructured":"Molina-Hernandez A, Nunez A, Arias-Montano JA (2000) Histamine H3-receptor activation inhibits dopamine synthesis in rat striatum. Neuroreport 11:163\u2013166","journal-title":"Neuroreport"},{"key":"2706_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/A:1011589218219","volume":"2","author":"AA Morley","year":"2001","unstructured":"Morley AA, Trainor KJ (2001) Lack of an effect of vitamin E on lifespan of mice. Biogerontology 2:109\u2013112","journal-title":"Biogerontology"},{"key":"2706_CR24","first-page":"529","volume":"26","author":"JZ Nowak","year":"1975","unstructured":"Nowak JZ, Pilc A (1975) The influence of mepyramine and burimamide on histamine induced catalepsy in the rat. Acta Physiol Pol 26:529\u2013532","journal-title":"Acta Physiol Pol"},{"key":"2706_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF03033506","volume":"13","author":"P Nowak","year":"2008","unstructured":"Nowak P, Bortel A, Dabrowska J, Biedka I, Slomian G, Roczniak W, Kostrzewa RM, Brus R (2008) Histamine H3 receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum. Neurotox Res 13:231\u2013240","journal-title":"Neurotox Res"},{"key":"2706_CR26","first-page":"397","volume":"13","author":"K Onodera","year":"1991","unstructured":"Onodera K (1991) Effects of antidepressants and antihistaminics on catalepsy induced by intracerebroventricular administration of histamine in mice. Methods Find Exp Clin Pharmacol 13:397\u2013403","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"2706_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF01993150","volume":"33","author":"K Onodera","year":"1991","unstructured":"Onodera K, Shinoda H (1991) Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons. Agents Actions 33:143\u2013146","journal-title":"Agents Actions"},{"key":"2706_CR28","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1046\/j.1471-4159.2002.00871.x","volume":"81","author":"JO Rinne","year":"2002","unstructured":"Rinne JO, Anichtchik OV, Eriksson KS, Kaslin J, Tuomisto L, Kalimo H, R\u00f6ytt\u00e4 M, Panula P (2002) Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem 81:954\u2013960","journal-title":"J Neurochem"},{"key":"2706_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1991.71.1.1","volume":"71","author":"JC Schwartz","year":"1991","unstructured":"Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71:1\u201351","journal-title":"Physiol Rev"},{"key":"2706_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0006-8993(81)90894-5","volume":"210","author":"JA Severson","year":"1981","unstructured":"Severson JA, Randall PK, Finch CE (1981) Genotypic influences on striatal dopaminergic regulation in mice. Brain Res 210:201\u2013215","journal-title":"Brain Res"},{"key":"2706_CR31","first-page":"85","volume":"53","author":"NS Sharpless","year":"1975","unstructured":"Sharpless NS, Muenter MD, Tyce GM (1975) Effect of l-DOPA on endogenous histamine metabolism. Med Biol 53:85\u201392","journal-title":"Med Biol"},{"key":"2706_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1046\/j.1471-4159.2000.0750540.x","volume":"75","author":"ML Vizuete","year":"2000","unstructured":"Vizuete ML, Merino M, Venero JL, Santiago M, Cano J, Machado A (2000) Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra. J Neurochem 75:540\u2013552","journal-title":"J Neurochem"},{"key":"2706_CR33","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1113\/jphysiol.2010.203257","volume":"589","author":"Y Yanovsky","year":"2011","unstructured":"Yanovsky Y, Li S, Klyuch BP, Yao Q, Blandina P, Passani MB, Lin JS, Haas HL, Sergeeva OA (2011) L-Dopa activates histaminergic neurons. J Physiol 589:1349\u20131366","journal-title":"J Physiol"}],"updated-by":[{"DOI":"10.1007\/s00213-022-06167-9","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"record-id":"37372"},{"DOI":"10.1007\/s00213-012-2706-0","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000}},{"DOI":"10.1007\/s00213-022-06167-9","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000}}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2706-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-012-2706-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2706-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2706-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:02:11Z","timestamp":1772708531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-012-2706-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,13]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2706"],"URL":"https:\/\/doi.org\/10.1007\/s00213-012-2706-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,13]]},"assertion":[{"value":"25 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ExpressionOfConcern","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Editorial Expression of Concern to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00213-022-06167-9","URL":"https:\/\/doi.org\/10.1007\/s00213-022-06167-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}